Skip to main content
SpringerLink
Log in

Dietary interventions in prostate cancer

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Our understanding of the relationship between diet and prostate cancer is still developing. Currently, randomized, controlled trials are under way that will yield evidence on which to base recommendations regarding dietary regimens, functional foods, and supplement use. For now, data mostly derive from epidemiologic investigations with limited ability to demonstrate cause and effect, or from benchtop research that may have limited application to in vivo systems, especially in humans. Insufficient evidence currently exists to support the use of specific dietary supplements or functional food. Clinicians striving for best clinical practice should therefore encourage weight management because data consistently show that overweight and obesity are associated with progressive disease and increased overall mortality from prostate cancer and other diseases, especially cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Doll R, Peto R: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981, 66:1191–1308.

    PubMed  CAS  Google Scholar 

  2. Aggarwal BB, Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006, 71:1397–1421.

    Article  PubMed  CAS  Google Scholar 

  3. Chan JM, Gann PH, Giovannucci EL: Role of diet in prostate cancer development and progression. J Clin Oncol 2005, 23:8152–8160.

    Article  PubMed  CAS  Google Scholar 

  4. Demark-Wahnefried W, Moyad MA: Dietary intervention in the management of prostate cancer. Current Opin Urol 2007, 17:168–174.

    Article  Google Scholar 

  5. Fleshner N, Zlotta AR: Prostate cancer prevention: past, present, and future. Cancer 2007, 110:1889–1899.

    Article  PubMed  CAS  Google Scholar 

  6. Shukla S, Gupta S: Dietary agents in the chemoprevention of prostate cancer. Nutr Cancer 2005, 53:18–32.

    Article  PubMed  CAS  Google Scholar 

  7. Thompson IM, Tangen CM, Klein EA, Lippman SM: Phase III prostate cancer prevention trials: are the costs justified? J Clin Oncol 2005, 23:8161–8164.

    Article  PubMed  Google Scholar 

  8. Canby-Hagino, Thompson IM: Mechanism of disease: prostate cancer—a model for cancer chemoprevention in clinical practice. Nature Clin Pract Oncol 2005, 2:255–261.

    Article  Google Scholar 

  9. Lamb DJ, Zhang L: Challenges in prostate cancer research: animal models for nutritional studies of chemoprevention and disease progression. J Nutr 2005, 135(12 S):3009S–3015S.

    PubMed  CAS  Google Scholar 

  10. Department of Health and Human Services, US Department of Agriculture: Dietary guidelines for Americans, 2005. Accessible at http://www.health.gov/dietaryguidelines. Accessed on January 2007.

  11. Pryor WA, Stahl W, Rock CL: Beta carotene: from biochemistry to clinical trials. Nutr Rev 2000, 58:39–53.

    Article  PubMed  CAS  Google Scholar 

  12. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group: The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J M 1994, 330:1029–1035.

    Article  Google Scholar 

  13. Omenn GS, Goodman GE, Thornquist MD, et al.: Risk factors for lung cancer and the intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst 1996, 88:1550–1559.

    Article  PubMed  CAS  Google Scholar 

  14. Weinstein SJ, Wright ME, Lawson KA, et al.: Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007, 16:1253–1259.

    Article  PubMed  CAS  Google Scholar 

  15. Bairati I, Meyer F, Jobin E, et al.: Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients. Int J Cancer 2006, 119:2221–2224.

    Article  PubMed  CAS  Google Scholar 

  16. Miller ER III, Pastor-Barriuso R, Dalal D, et al.: Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005, 142:37–46.

    PubMed  CAS  Google Scholar 

  17. Potter JD: Food and Cancer Prevention II: summary of the meeting. Cancer Letters 1997, 114:337–338.

    Article  PubMed  CAS  Google Scholar 

  18. Bjelakovic G, Nikolova D, Glund LL, et al.: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007, 297, 842–857.

    Article  PubMed  CAS  Google Scholar 

  19. Lawson KA, Wright ME, Subar A, et al.: Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst 2007, 99:754–764.

    Article  PubMed  CAS  Google Scholar 

  20. Food and Nutrition Board/National Academy of Sciences/Institutes of Medicine. Dietary Reference Intakes. Accessible at http://www.iom.edu/Object.File/Master/21/372/0.pdf. Accessed on January 10, 2008.

  21. Reid ME, Stratton MS, Lillico AJ, et al.: A report of high-dose selenium supplementation: response and toxicities. J Trace Elements Med Biol 2004, 18:69–74.

    Article  CAS  Google Scholar 

  22. Williams R, Ansford A: Acute selenium toxicity: Australia’s second fatality. Pathol 2007, 39:289–290.

    Article  Google Scholar 

  23. Bemis DL, Capodice JL, Costello JE, et al.: The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer. Current Oncol Reports 2006, 8:228–236.

    Article  CAS  Google Scholar 

  24. Schmid HP, Engeler DS, Pummer K, Schmitz-Drager BJ: Prevention of prostate cancer: more questions than data. Recent Results Cancer Res 2007, 174:101–107.

    PubMed  CAS  Google Scholar 

  25. Ansari MS, Gupta NP: A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. Br J Urol Int 2003, 92:375–378.

    CAS  Google Scholar 

  26. Bunker CH, McDonald AC, Evans RW, et al.: A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk. Nutr Cancer 2007, 57:130–137.

    PubMed  CAS  Google Scholar 

  27. Kucuk O, Sarkar FH, Sakr W, et al.: Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2001, 10:861–868.

    PubMed  CAS  Google Scholar 

  28. Hoenjet KM, Dagnelie PC, Delaere KP, et al.: Effect of a nutritional supplement containing vitamin E, selenium, vitamin C and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study. Euro Urol 2005, 47:433–439.

    Article  CAS  Google Scholar 

  29. Kranse R, Dagnelie PC, van Kemende MC, et al.: Dietary intervention in prostate cancer patients: PSA response in a randomized double-blind placebo-controlled trial. Int J Cancer 2005, 113:835–840.

    Article  PubMed  CAS  Google Scholar 

  30. Schröder FH, Roobol MJ, Boevé ER, et al.: Randomized double blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement. Euro Urol 2005, 48:922–931.

    Article  CAS  Google Scholar 

  31. Hamilton-Reeves JM, Rebello SA, Thomas W, et al.: Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen-beta expression or serum hormonal profiles in men at high risk of prostate cancer. J Nutr 2007, 137:1769–1775.

    PubMed  CAS  Google Scholar 

  32. Kumar NB, Cantor A, Allen K, et al.: The specific role of isoflavones in reducing prostate cancer risk. Prostate 2004, 59:141–147.

    Article  PubMed  CAS  Google Scholar 

  33. Dalais FS, Meliala A, Wattanapenpaiboon N, et al.: Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Urol 2004, 64:510–515.

    Article  PubMed  Google Scholar 

  34. Bylund A, Lundin E, Zhang JX, et al.: Randomised controlled short-term intervention pilot study on rye bread in prostate cancer. Euro J Cancer Prevent 2003, 12:407–415.

    Article  CAS  Google Scholar 

  35. Ornish D, Weidner G, Fair WR, et al.: Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 2005, 174:1065–1070.

    Article  PubMed  Google Scholar 

  36. Lippman SM, Goodman PJ, Klein EA, et al.: Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 2005, 97:94–102.

    Article  PubMed  CAS  Google Scholar 

  37. Marshall JR, Sakr W, Wood D, et al.: Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 2006, 15:1479–1484.

    Article  PubMed  CAS  Google Scholar 

  38. Etminan M, FitzGerald JM, Gleave M, et al.: Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control 2005, 16:1125–1131.

    Article  PubMed  Google Scholar 

  39. MacInnes RJ, English DR: Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 2006, 17:989–1003.

    Article  Google Scholar 

  40. Rodriguez C, Freedland SJ, Deka A, et al.: Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 2007, 16:63–69.

    Article  PubMed  Google Scholar 

  41. Wright ME, Chang SC, Schatzkin A, et al.: Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 2007, 109:675–684.

    Article  PubMed  Google Scholar 

  42. Doyle C, Kushi LH, Byers T, et al.: Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 2006, 56:323–353.

    Article  PubMed  Google Scholar 

  43. World Cancer Research Fund/American Institute for Cancer Research: Second Expert Report, Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 2007.

    Google Scholar 

  44. Halabi S, Ou SS, Vogelzang NJ, Small E: Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer. Cancer 2007, 110:1478–1484.

    Article  PubMed  Google Scholar 

  45. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, et al.: Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metabol Care 2007, 10:433–442.

    Article  Google Scholar 

  46. Laviano A, Meguid MM, Inui A, et al.: Therapy insight: cancer anorexia-cachexia syndrome—when all you can eat is yourself. Nature Clin Pract Oncol 2005, 2:158–165.

    Article  CAS  Google Scholar 

  47. Podgorski I, Linebaugh BE, Sloane BF: Cathepsin K in the bone microenvironment: link between obesity and prostate cancer? Biochem Soc Transactions 2007, 35:701–703.

    Article  CAS  Google Scholar 

  48. DeMarzo AM, Platz EA, Sutcliffe S, et al.: Inflammation in prostate carcinogenesis. Nature Rev Cancer 2007, 7:256–269.

    Article  CAS  Google Scholar 

  49. Freedland SJ, Platz EA: Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 2007, 29:88–97.

    Article  PubMed  Google Scholar 

  50. Demark-Wahnefried W, Aziz N, Rowland J, Pinto BM: Riding the crest of the teachable moment: Promoting long-term health after the diagnosis of cancer. J Clin Oncol 2005, 23:5814–5830.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center, University of Texas, 1155 Pressler Street, CPB 3.3245, Houston, TX, 77030, USA

    Wendy Demark-Wahnefried

Authors
  1. Wendy Demark-Wahnefried
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wendy Demark-Wahnefried.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Demark-Wahnefried, W. Dietary interventions in prostate cancer. Curr Urol Rep 9, 217–225 (2008). https://doi.org/10.1007/s11934-008-0038-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-008-0038-8

Keywords

Search

Navigation